Global Thyroid Eye Disease Treatment Market, By Drug (Monoclonal Antibody, Vitamin, Corticosteroid, Others), Treatment (Surgery, Radioactive Iodine Therapy, Medication), Diagnosis (Imaging Test, Orbital Ultrasound, Blood Test, Radioactive Iodine Uptake Test, Physical Exam), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Topical, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Thyroid Eye Disease Treatment Market
Thyroid eye disease treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 9.34% in the above mentioned forecast period.
Thyroid eye disease is an autoimmune disorder in which immune cells of the body attack the thyroid gland by secreting an excess amount of thyroid hormone. In this condition eye muscles, eye lids, fatty tissue behind the gland and tear glands become inflamed. It is also known as grave’s orbitopathy or ophthalmopathy. Symptoms of this condition are puffiness around the eye, redness, pain, bulging of eyes, dry eyes, irritation, deep headache and decreased vision.
Rise in the prevalence of thyroid eye disease, growing healthcare expenditure, and favourable reimbursement policies for the treatment of thyroid disorder, growing government funding, rising awareness about the complications associated with the thyroid disorder are the factors that will expand the thyroid eye disease treatment market. Rise in the research and development activities and rise in the development of novel therapy for thyroid eye disease treatment will provide beneficial opportunities for the thyroid eye disease treatment market in the forecast period of 2021-2028.
However, high cost of treatment, complication from the disease and side effects associated with the drugs are the factors that will hinder the market growth and will further challenge the thyroid eye disease treatment market in the forecast period mentioned above.
This thyroid eye disease treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the thyroid eye disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Thyroid Eye Disease Treatment Market Scope and Market Size
The thyroid eye disease treatment market is segmented on the basis of drug, treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug, the thyroid eye disease treatment market is segmented into monoclonal antibody, vitamin, corticosteroid and others.
- On the basis of treatment, the thyroid eye disease treatment market is segmented into surgery, radioactive iodine therapy and medication.
- On the basis of diagnosis, the thyroid eye disease treatment market is segmented into imaging test, orbital ultrasound, blood test, radioactive iodine uptake test, physical exam and others.
- On the basis of dosage, the thyroid eye disease treatment market is segmented into tablet, injection and others.
- On the basis of route of administration, the thyroid eye disease treatment market is segmented into oral, intravenous, topical and others.
- On the basis of end-users, the thyroid eye disease treatment market is segmented into clinic, hospital and others.
The thyroid eye disease treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Thyroid Eye Disease Treatment Market Country Level Analysis
Thyroid eye disease treatment market is analyzed and market size information is provided by the country, drug, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the thyroid eye disease treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the thyroid eye disease treatment market due to the presence of major key players, rising prevalence of disease, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific and Europe is expected to grow during the forecast period of 2021-2028 due to the availability of treatment options, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Thyroid eye disease treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Thyroid Eye Disease Treatment Market Share Analysis
Thyroid eye disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to thyroid eye disease treatment market research.
The major players covered in the thyroid eye disease treatment market report are Bausch & Lomb Incorporated, Allergan, Akorn, Incorporated, Mylan N.V., Kala Pharmaceuticals, Horizon Therapeutics plc, Sumitomo Corporation, Johnson & Johnson Private Limited, Novartis AG, Pfizer Inc., Sanofi, Merck KGaA, LEO Pharma A/S, Cipla Inc., GlaxoSmithKline plc, AstraZeneca, Abbott, Bayer AG, Eyevance Pharmaceuticals LLC, Merck Sharp & Dohme Corp., AbbVie Inc., and RLC Labs, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-